![](/sites/g/files/knoqqb79811/themes/site/nir_pid2746/client/images/TopBanners_Desktop-IR.jpg)
Investor Overview
Investor Overview
Corporate ProfilescPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery — with the goal of transforming infused therapies, advancing patient care and reducing healthcare costs.
Stock Quote
(Common Stock)
|
Data Provided by Refinitiv. Minimum 15 minutes delayed.